BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38250759)

  • 1. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
    Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
    Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
    Yang B; Wang Y; Liu T; Zhang M; Luo T
    Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients.
    Hua L; Lei P; Hu Y
    Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma.
    Chen Y; Zhao B; Wang X
    BMC Cancer; 2020 Oct; 20(1):1022. PubMed ID: 33087099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L; Zhou H; Su H
    BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
    Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
    Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.